What are you looking for? Search Common searches: Intranet, Contact, Map, Professionals, Teaching units, Research groups, Fulltext search Tipus de contingut Professionals Projects Teaching Units Collaborating entities News Activities - Any - Search News Vall d’Hebron, AstraZeneca and Tucuvi launch the AZerca project to follow up on patients with heart failure The project evaluates the feasibility of implementing LOLA, an AI-based virtual medical assistant with conversational technology that provides personalized tracking to patients suffering from heart failure. News 62% of children with a ventricular assist device in Spain receive a new heart within nine months A study, in which Vall d'Hebron has participated, has analysed all the interventions of this type carried out between 2006 and 2020. Activities Jornada Sumem dades multipliquem coneixement Activities Curso de Aspectos claves para mejorar la vacunación en migrantes recién llegado Dirección: Victoria López López i Dra Núria Serre Delcor Estructura del curso: El curso tiene 5 secciones que se desarrollan presencialmente (en el aula o por videoconferencia) durante 3 días, con una duración de 10 horas en total. Activities Defensa de tesi 'Caracterització genòmica, estructura poblacional i determinants de resistència a antimicrobians de Shigella sonnei, Shigella flexneri i Escherichia coli aïllats d'homes que mantenen relacions sexuals amb homes' Doctorand: Albert Moreno Mingorance, Microbiologia (VHIR) Director: Dr. Juanjo González López Tutor: Dr. Juanjo González López Activities Defensa de tesi 'Aplicació adaptada de la NGS per millorar la caracterització genètica dels pacients de complex esclerosi tuberosa i atròfia muscular espinal' Doctoranda: Laura Blasco Pérez, Medicina genètica VHIR Directors: Dra. Elena García Arumí i Dr. Eduardo F Tizzano Tutor: Dr. Francisco Rodríguez Frias News D-Sight, a Vall d’Hebron spin-off, raises 1 million euros to develop its drug to combat early-stage diabetic retinopathy and glaucoma The investment will enable D-Sight to progress with the first phase of clinical validation of their drug for early-stage diabetic retinopathy and glaucoma. News Vall d'Hebron participates in a guide of recommendations for clinical trials with drug combinations for childhood cancer Dr. Lucas Moreno is the first author of the international work that presents a series of considerations for early phase studies with the aim of accelerating the arrival of new therapies to patients. News A genetic study indicates that ADHD is associated with lower life expectancy This is the result of a study led by the Vall d'Hebron Research Institute (VHIR), the IISPV, the University Hospital Pere Mata Institute and the CIBER. News Recruitment of participants for a study on prevention of chronic malnutrition in Angola concludes The research, which is part of the CRESCER project in which Vall d'Hebron participates, has 1423 pregnant women among whom two different interventions will be tested. Pagination Previous page ‹‹ Page 151 Next page ››